Literature DB >> 25354102

The FDA warning on antidepressants and suicidality--why the controversy?

Marc B Stone1.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 25354102     DOI: 10.1056/NEJMp1411138

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Antidepressant prescription rates and suicide attempt rates from 2004 to 2016 in a nationally representative sample of adolescents in the USA.

Authors:  M Plöderl; M P Hengartner
Journal:  Epidemiol Psychiatr Sci       Date:  2018-04-10       Impact factor: 6.892

2.  Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis.

Authors:  Cosima Locher; Helen Koechlin; Sean R Zion; Christoph Werner; Daniel S Pine; Irving Kirsch; Ronald C Kessler; Joe Kossowsky
Journal:  JAMA Psychiatry       Date:  2017-10-01       Impact factor: 21.596

3.  A decline in depression treatment following FDA antidepressant warnings largely explains racial/ethnic disparities in prescription fills.

Authors:  Nicholas J Carson; Ana M Progovac; Ye Wang; Benjamin L Cook
Journal:  Depress Anxiety       Date:  2017-09-29       Impact factor: 6.505

Review 4.  Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review.

Authors:  Sheng-Min Wang; Changsu Han; Won-Myoung Bahk; Soo-Jung Lee; Ashwin A Patkar; Prakash S Masand; Chi-Un Pae
Journal:  Chonnam Med J       Date:  2018-05-25

5.  Placebos Are Part of the Solution, Not the Problem. An Exemplification of the Case of Antidepressants in Pediatric Chronic Pain Conditions.

Authors:  Cosima Locher; Jens Gaab; Charlotte Blease; Marc Inderbinen; Linda Kost; Helen Koechlin
Journal:  Front Psychiatry       Date:  2020-01-21       Impact factor: 4.157

6.  Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts.

Authors:  Chiara Fabbri; Saskia P Hagenaars; Catherine John; Alexander T Williams; Nick Shrine; Louise Moles; Ken B Hanscombe; Alessandro Serretti; David J Shepherd; Robert C Free; Louise V Wain; Martin D Tobin; Cathryn M Lewis
Journal:  Mol Psychiatry       Date:  2021-03-22       Impact factor: 13.437

7.  Clinical, demographic, and genetic risk factors of treatment-attributed suicidality in >10,000 Australian adults taking antidepressants.

Authors:  Adrian I Campos; Enda M Byrne; Frank Iorfino; Chiara Fabbri; Ian B Hickie; Cathryn M Lewis; Naomi R Wray; Sarah E Medland; Miguel E Rentería; Nicholas G Martin
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2022-07-14       Impact factor: 3.358

Review 8.  Methodological Flaws, Conflicts of Interest, and Scientific Fallacies: Implications for the Evaluation of Antidepressants' Efficacy and Harm.

Authors:  Michael P Hengartner
Journal:  Front Psychiatry       Date:  2017-12-07       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.